메뉴 건너뛰기
American Journal of Hematology
Volumn 77, Issue 2, 2004, Pages 196-197
Response of myasthenia gravis to rituximab in a patient with non-Hodgkin lymphoma
Author keywords

Myasthenia gravis; Rituximab
Indexed keywords

AUTOANTIBODY; CD20 ANTIGEN; CHOLINERGIC RECEPTOR; CHOLINERGIC RECEPTOR ANTIBODY; CYCLOPHOSPHAMIDE; PREDNISONE; PYRIDOSTIGMINE; RITUXIMAB; VINCRISTINE;
EID: 4644352009     PISSN: 03618609     EISSN: None     Source Type: Journal    
DOI: 10.1002/ajh.20169     Document Type: Article
Times cited : (62)
References (8)
  • 1
    • 0031927167 scopus 로고    scopus 로고
    • Immune regulation and myasthenia gravis
    • Ragheb S, Lisak RP. Immune regulation and myasthenia gravis. Ann NY Acad Sci 1998;841:210-224.
    • (1998) Ann NY Acad Sci , vol.841 , pp. 210-224
    • Ragheb, S.1    Lisak, R.P.2
  • 2
    • 0032421041 scopus 로고    scopus 로고
    • Intravenous immunoglobulin for the treatment of myasthenia gravis
    • Howard JF. Intravenous immunoglobulin for the treatment of myasthenia gravis. Neurology 1998;51:S30-S36.
    • (1998) Neurology , vol.51
    • Howard, J.F.1
  • 3
    • 0021272605 scopus 로고
    • Expression of human B-cell-associated antigens on leukemias and lymphomas: A model of human B cell differentiation
    • Anderson KC, Bates MP, Slaughenhoupt BL, Pinkus GS, Schlossman SF, Nadler LM. Expression of human B-cell-associated antigens on leukemias and lymphomas: a model of human B cell differentiation. Blood 1984;63:1424-1433.
    • (1984) Blood , vol.63 , pp. 1424-1433
    • Anderson, K.C.1    Bates, M.P.2    Slaughenhoupt, B.L.3    Pinkus, G.S.4    Schlossman, S.F.5    Nadler, L.M.6
  • 4
    • 0034633654 scopus 로고    scopus 로고
    • Rituximab for myasthenia gravis developing after bone marrow transplant
    • Zaja F, Russo D, Fuga G, Perella G, Baccarani M. Rituximab for myasthenia gravis developing after bone marrow transplant. Neurology 2000;55:1062-1063.
    • (2000) Neurology , vol.55 , pp. 1062-1063
    • Zaja, F.1    Russo, D.2    Fuga, G.3    Perella, G.4    Baccarani, M.5
  • 5
    • 0344874207 scopus 로고    scopus 로고
    • Successful treatment of refractory myasthenia gravis using rituximab: A pediatric case report
    • Wylam ME, Anderson PM, Kuntz NL, Rodriguez V. Successful treatment of refractory myasthenia gravis using rituximab: a pediatric case report. J Pediatr 2003;143(5):674-677.
    • (2003) J Pediatr , vol.143 , Issue.5 , pp. 674-677
    • Wylam, M.E.1    Anderson, P.M.2    Kuntz, N.L.3    Rodriguez, V.4
  • 6
    • 4644265812 scopus 로고    scopus 로고
    • Rituximab for the treatment of autoimmune disease
    • abstr 3770
    • Zaya F, Russo D, De Vita S, et al. Rituximab for the treatment of autoimmune disease. Blood 2001;98(11) [abstr 3770].
    • (2001) Blood , vol.98 , Issue.11
    • Zaya, F.1    Russo, D.2    De Vita, S.3
  • 7
    • 0037819344 scopus 로고    scopus 로고
    • An overview of the current clinical use of the anti-CD20 monoclonal antibody rituximab
    • Boye J, Elter T, Engert E. An overview of the current clinical use of the anti-CD20 monoclonal antibody rituximab. Ann Oncol 2003;14:520-535.
    • (2003) Ann Oncol , vol.14 , pp. 520-535
    • Boye, J.1    Elter, T.2    Engert, E.3
  • 8
    • 0037638841 scopus 로고    scopus 로고
    • Rituximab therapy and autoimmune disorders. Prospects for anti-B-cell therapy
    • Silverman G, Weisman S. Rituximab therapy and autoimmune disorders. Prospects for anti-B-cell therapy. Arthritis Rheum 2003;48:1484-1492.
    • (2003) Arthritis Rheum , vol.48 , pp. 1484-1492
    • Silverman, G.1    Weisman, S.2

* 이 정보는 Elsevier사의 SCOPUS DB에서 KISTI가 분석하여 추출한 것입니다.